Skip to content

Observation on the clinical effect of acupoint catgut embedding combined with atorvastatin in the treatment of dyslipidemia

Observation on the clinical effect of acupoint catgut embedding combined with atorvastatin in the treatment of dyslipidemia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032792
Enrollment
Unknown
Registered
2020-05-10
Start date
2020-05-09
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

Sponsors

Community Health Service Center, Malu Town, Jiading District, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Volunteer to participate in the study and sign informed consent. 2. The age is between 60 and 75 years old (including 60 and 75 years old), and the gender is unlimited. 3. Serum total cholesterol >= 5.2mmol/l; serum triglyceride >= 1.7mmol/l; high-density lipoprotein = 3.4mmol/l; one or more of the above four indexes were met. 4. At the same time, the above three items can be included in this study.

Exclusion criteria

Exclusion criteria: 1. Serious heart related diseases: LDL-C 8.5%). 8. History of cancer. 9. Subjects who are unreliable (such as drug abuse, unwillingness to comply with the agreement or mental illness), do not cooperate with the agreement or procedural requirements. Patients who meet any of the above conditions shall be excluded.

Design outcomes

Primary

MeasureTime frame
Low density lipoprotein;High density lipoprotein;total cholesterol;

Secondary

MeasureTime frame
weight;

Countries

China

Contacts

Public ContactLiu Meiling

Community Health Service Center, Malu Town, Jiading District, Shanghai

254234366@qq.com+86 13917705510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026